Sb Investment Advisers (Uk) LTD Vir Biotechnology, Inc. Transaction History
Sb Investment Advisers (Uk) LTD
- $11 Billion
- Q1 2025
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 16,684,041 shares of VIR stock, worth $84.3 Million. This represents 0.99% of its overall portfolio holdings.
Number of Shares
16,684,041
Previous 16,684,041
-0.0%
Holding current value
$84.3 Million
Previous $122 Million
11.72%
% of portfolio
0.99%
Previous 1.08%
Shares
6 transactions
Others Institutions Holding VIR
# of Institutions
255Shares Held
92.6MCall Options Held
257KPut Options Held
261K-
Black Rock Inc. New York, NY16.4MShares$83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$64.7 Million0.0% of portfolio
-
State Street Corp Boston, MA5.73MShares$28.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.68MShares$13.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.3MShares$11.6 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $670M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...